Clinical Trials Browser

Phase 1/2 × Advanced Malignant Solid Neoplasm × Other solid neoplasm × Clear all

NCT04552704 2023-08-02

CD24Fc for the Treatment of Immune Related Adverse Events in Patients With Advanced Solid Tumors, TIRAEC Study

Phase 1/2 Terminated

3 enrolled 12 charts

Other solid neoplasm

Advanced Malignant Solid Neoplasm